Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Reliant Glycosciences
AddedFeb 16, 2024
UpdatedJun 18, 2026
Reliant Glycosciences

Reliant Glycosciences

Pre-Seed

Reliant Glycosciences: Biotech firm developing diagnostic tools for IgA nephropathy.

HQ
Birmingham, AL, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Reliant Glycosciences, LLC was founded as a spin-out from the University of Alabama at Birmingham, leveraging technology developed in Dr. Jan Novak's laboratory in the Department of Microbiology. The company is dedicated to advancing diagnostic and prognostic tools for patients suffering from IgA nephropathy, a kidney disease caused by the accumulation of IgA antibodies. Reliant Glycosciences aims to improve patient outcomes through innovative biotechnology solutions, focusing on a niche but impactful market within nephrology.

Notably, Dr. Jan Novak, whose research underpins the company's core technology, is a key figure affiliated with Reliant Glycosciences. The company has made significant strides in identifying specific autoantibodies linked to IgA nephropathy, positioning itself as a leader in this specialized field. Through its cutting-edge diagnostic tools, Reliant Glycosciences has the potential to significantly impact patient care and disease management for those affected by this chronic kidney condition.

Reliant Glycosciences - Similar Companies

Glycologix logo

Glycologix

glycologix.com

NatGlycan logo

NatGlycan

Amplified Sciences logo

Amplified Sciences

Accelevir Diagnostics logo

Accelevir Diagnostics

Nephrosant logo

Nephrosant

Gaskiya Diagnostics logo

Gaskiya Diagnostics

Enable Biosciences logo

Enable Biosciences

DxDiscovery logo

DxDiscovery

dxdiscovery.com

IgGenix logo

IgGenix

iggenix.com

Glycomine logo

Glycomine

glycomine.com

Gamma Diagnostics logo

Gamma Diagnostics

Ionica Sciences logo

Ionica Sciences

TAI Diagnostics logo

TAI Diagnostics

Renibus Therapeutics logo

Renibus Therapeutics

Glycotest logo

Glycotest

glycotest.com

Reliant Glycosciences - Quick Facts

Who are Reliant Glycosciences' competitors?

Companies similar to Reliant Glycosciences include Glycologix, NatGlycan, Amplified Sciences and Accelevir Diagnostics.

When was Reliant Glycosciences founded?

Reliant Glycosciences was founded in 2015.

Where is Reliant Glycosciences' headquarters located?

Reliant Glycosciences' headquarters is located in Birmingham, AL, US.

How much has Reliant Glycosciences raised to-date?

As of Aug 30, 2022, Reliant Glycosciences has raised a total of $1.2M (USD).

How many employees does Reliant Glycosciences have?

Reliant Glycosciences has 5 employees as of Feb 4, 2024.

Reliant Glycosciences - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Diagnostic Tools
Tags
  • Data Information
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research